Progressive supranuclear palsy (PSP) is a rare neurodegenerative condition that ... Patients may demonstrate the “rocket sign” during which they try to rapidly rise out of a chair and immediately ...

Background Progressive supranuclear palsy and Parkinson's disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to ...

More information: Miriam Scarpa et al, Post mortem validation and mechanistic study of UCB‐J in progressive supranuclear palsy patients' brains, Alzheimer's & Dementia (2024). DOI: 10.1002/alz.14409 ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share ...

Book your place on PSPA’s free online masterclass at 6.30pm on 25 March to learn more about Progressive Supranuclear Palsy ...

The levels of neurofilament light chain in the cerebrospinal fluid of people with progressive supranuclear palsy were found to be higher than those of people with Alzheimer's disease (effect size = ...

Inflammatory Trigger a New Clue in Alzheimer's Jan. 6, 2023 — Researchers have identified a new trigger of brain inflammation in Alzheimer's disease and progressive supranuclear palsy ...

and cerebral cortex of patients with progressive supranuclear palsy (PSP). This group has now shown that a low ratio of these tau forms reliably differentiates patients with PSP from controls and ...

Historically, frontotemporal lobar degeneration (FTLD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were classified on the basis of distinct clinical and pathological ...